Oncology

Top news of the day from across the healthcare landscape.

Endocrinologists seek to create an observational registry so researchers can study thyroid incidentalomas systematically.

Depression and anxiety strongly influences the success of cancer treatment.

Atezolizumab (Tecentriq) approved for locally advanced or metastatic urothelial carcinoma.

Drug-drug and drug-food interactions are evaluated in 58 oral chemotherapeutics.

Uneven distribution of the signaling protein c-Myc could aid the development of cancer vaccines.

The United States reduced cancer mortality by 26% overall, falling short of the 50% reduction goal set by the American Cancer Society.

Sorafenib for advanced hepatocellular carcinoma may not offer the significantly lengthened life expectancy reported in clinical trials.

Sorafenib for advanced hepatocellular carcinoma may not offer the significantly lengthened life expectancy reported in clinical trials.

Most patients with locally advanced non-small cell lung cancer with mediastinal lymph node involvement are generally not considered good candidates for surgery.

Opdivo approved for patients with relapsed or refractory classical Hodgkin lymphoma.

Imbruvica approved for use in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Researchers found a protective effect against cancer in patients with autism spectrum disorder.

Lenvatinib with everolimus found to improve progression-free survival in RCC patients.

Top news of the day from across the health care landscape.

Subcapsular sinus macrophages may influence cancer mortality.

Blocking estrogen production by using an aromatase inhibitor stopped seizures in animal models.

Antiandrogen therapy plus radiotherapy shows promise reducing prostate cancer mortality.

Patients who receive antiandrogen therapy plus radiotherapy decrease their risk of death to 17%.

A high intake of fruit and vegetables in adolescence is linked to a reduced risk of breast cancer, but high alcohol consumption could increase the risk.

Researchers gain greater understanding of genetic and biological basis of diseases such as Alzheimer’s disease, cancer, diabetes, and rheumatoid arthritis.

Hsp90 inhibitors could improve aggressive, resistant prostate cancer treatment.

Recent advances and updates in oncology and cancer drug development.

A repository of biopsy tissue was created from patients with leukemia and lymphoma.

More knowledge about deadly glioblastoma tumors has been discovered.

Patients taking mitoxantrone for multiple sclerosis found to have higher rates of breast and colorectal cancers and leukemia.

Patients administered mitoxantrone for multiple sclerosis carry higher rates of breast and colorectal cancers and leukemia.

Active surveillance seems to be safe in patients who are low risk, and certain patients at intermediate risk.